Oregon Recalls THC Vape Pods Containing Unapproved Additives

Aug.24.2022
Oregon Recalls THC Vape Pods Containing Unapproved Additives
18,000 THC e-cigarette pods recalled in Oregon due to unauthorized non-cannabis additives, potentially causing respiratory issues.

During an investigation conducted by the Oregon Liquor Control Commission (OLCC) this month, it was found that over 18,000 THC (tetrahydrocannabinol) electronic cigarette pods sold in Oregon between November 2021 and July 2022 contained unapproved non-cannabis additives, which could potentially pose health issues for the respiratory system.


Here is what the recall for the electronic cigarettes shopping cart label looks like:


The marijuana regulatory agency in the state of Oregon has issued a recall for 18,000 electronic THC vape pods manufactured by YHN. The recall notice is printed on the back of the packaging (as shown in the photo from OLCC). The OLCC has initiated the recall of these pods, which were manufactured by YHN and sold in two stores located in the eastern Oregon town of Ontario.


Weedology and The Bud House are two pharmacies in Ontario that sell electronic cigarette pods. They have voluntarily pulled the recalled YHN products from their shelves. So far, the OLCC has not received any reports from consumers who have experienced negative health effects from using these YHN products.


We encourage consumers who have purchased unapproved products to return them to OLCC-licensed retailers or dispose of them. Individuals who have health concerns regarding recalled e-cigarette products should contact their healthcare provider.


The main culprit: Soybean oil.


As part of their ongoing independent investigation, officials from the OLCC tested a range of products from the YHN brand and found that some of their flavoring cartridges for inhalable cannabis may contain soybean oil, which contains triglycerides of glycerol and is prohibited for use in e-cigarette products in Oregon.


Soybean oil is considered a generally recognized as safe (GRAS) food additive by the U.S. Food and Drug Administration. However, this classification is based on ingestion rather than inhalation. When soybean oil is heated into vapor and inhaled, the triglycerides in it may cause various long and short-term health problems, including lipoid pneumonia, a rare lung disease that can cause lung inflammation and breathing difficulties.


Risk: Lipoid Pneumonia


According to data from the National Institutes of Health in the United States, the incidence of lipoid pneumonia is increasing with the rise of nicotine and tetrahydrocannabinol (THC) electronic cigarettes.


According to the National Institutes of Health, an electronic cigarette is defined as a device that uses heat to produce aerosol inhaled by the user from a liquid containing various chemicals, including but not limited to nicotine, artificial flavors, or marijuana. Their guidelines were last updated as of June 2022. A series of cases completed in North Carolina observed five previously healthy individuals who had no underlying conditions, experienced acute respiratory failure requiring hospitalization, and were found to frequently expose themselves to vaporized aerosol in July and August 2019.


In 2019, a vaping-related lung illness known as EVALI resulted in 60 deaths and over 2,800 hospitalizations. This illness was caused by the use of illegal THC vape pods containing vitamin E oil. While this oil has FDA approval for use in a variety of products, it is not suitable for inhalation via vaporization. In response to the EVALI outbreak, Oregon and other legal cannabis states have implemented strict regulations prohibiting certain additives such as vitamin E oil, squalene, and propylene glycol in cannabis vape pods.


Health risks associated with inhaling soybean oil have been observed in both food seasoning and production factories. In 2002, a microwave popcorn factory experienced a mysterious outbreak of bronchiolitis obliterans. Officials investigating the incident at the Centers for Disease Control and Prevention found that workers in the factory had lung problems caused by inhaling aerosolized byproducts of heated soybean oil.


Further punishment will depend on the intent of the production.


In the OLCC investigation into YHN's vape pod, flavors such as "Fruit Blend" and "Green Crack" were tested. Independent testing revealed the presence of ingredients that match those found in soybean oil, a substance banned for use in e-cigarettes in Oregon. It was also discovered that YHN's labeling only partially complied with Oregon's regulations for inhalable cannabinoid products.


The ingredient list of the YHN e-cigarette products that were recalled did indeed include artificial flavorings, and the products were correctly classified according to OLCC rules. However, YHN did not follow OLCC requirements to further break down the ingredients in their artificial flavorings to disclose the presence of soybean oil.


YHN may face a fine of $4,950 or have their marijuana license revoked. These are two very different outcomes, and the punishment may depend on whether OLCC determines that the prohibited additives were intentionally added or due to negligent oversight.


Announcement:


This article has been compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the viewpoint of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the article's content. The article's translation is only intended for communication and research within the industry.


Due to limitations in the translator's proficiency, the compiled article may not express the same meaning as the original text. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the position and statements of the Chinese government in relation to any issues pertaining to domestic affairs, Hong Kong, Macau, Taiwan, and foreign affairs.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
An October 2026 review of U.S. state vapor product directories found KUMI 6 SCENIC 50K listed in Louisiana and Nebraska. Louisiana classifies 20 related product entries as “FDA EXEMPTION.” The SCENIC platform is marketed in both conventional nicotine-salt and NoNic6 formulations, each advertised with 22mL e-liquid capacity and up to 50,000 puffs. U.S. wholesaler Midwest Goods listed both versions in August 2025 with a suggested retail price of $19.99 each. The NoNic6 version is associated with 6-methylnicotine and is also marketed by some distributors as “nicotine-free.”
product
Oct.27
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Latest UK ONS Data: 54% of Vapers Are Former Cigarette Smokers, 26% Also Smoke and 20% Never Smoked Regularly
Former cigarette smokers accounted for an estimated 54% of current e-cigarette users in Great Britain in 2025, while 26% also smoked cigarettes and 20% had never regularly smoked, according to a 2Firsts analysis of Office for National Statistics (ONS) data. Among former cigarette smokers who currently vape, approximately 81% used e-cigarettes daily, compared with about 50% of dual users. The ONS found that 33.8% of current cigarette smokers also vaped in 2025, up from 10.6% in 2014. Approximately 1.1 million adults who had never regularly smoked cigarettes used e-cigarettes, representing 2.9% of that population, compared with 0.2% in 2014. The figures highlight differences in the composition, frequency of use and long-term trends across Britain's vaping population.
DATA
Oct.14
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
Athletes Back Skoka's $21.5 Million Nicotine Pouch Venture: Can Its Consumer Health Founder Make an FDA-Focused Strategy Pay Off?
U.S. nicotine pouch startup Skoka Inc. has raised $21.5 million and committed $15 million to an FDA regulatory and scientific research program. Founder Dan Aziz previously built dietary supplement brand Premama, which was acquired by Dr. Reddy's Laboratories in 2023. Skoka is combining proprietary formulations, ingredient transparency and equity investment from professional athletes. The company submitted a bundled PMTA covering 55 products on October 1, 2026. Aziz said Skoka declined an opportunity to enter retail in 2025, prioritizing product research and regulatory submissions instead. It now targets a U.S. retail launch in 2027, subject to FDA requirements. Its products have not received marketing authorization.
Business
Nov.04
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
Ahead of the 2026 NACS Show, 2Firsts interviewed Chris Rapanick, NACS managing director of research, on changes reshaping the U.S. convenience-store tobacco and nicotine market. NACS data show cigarette sales declining while smokeless alternatives, including nicotine pouches, continue to grow. The interview also examines higher OTP margins, shifting backbar space, weaker store traffic, regulatory uncertainty and NACS’ outlook for 2027, offering a retailer-side view of one of the world’s largest nicotine markets.
Interview
Oct.03
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Vaping brand PIXL has introduced the PIXL 5K reusable prefilled pod device in the UK, featuring a 2ml prefilled pod and a 4ml refill container with a combined e-liquid capacity of 6ml. The device uses 20mg/ml nicotine salt e-liquid and is advertised to deliver up to approximately 5,000 puffs. Available through UK retailers by August 2026, the PIXL 5K sits alongside the existing 12ml PIXL 8000. The UK's Vaping Products Duty took effect on October 1 at £0.22 per millilitre, producing theoretical duty amounts of £1.32 and £2.64 for the two products' respective full refill sets.
product
Oct.10
UK Extends Age-18 Rules to Zero-Nicotine Vapes and Nicotine Pouches From Oct. 29, Bans Vending Machines and Promotional Giveaways
UK Extends Age-18 Rules to Zero-Nicotine Vapes and Nicotine Pouches From Oct. 29, Bans Vending Machines and Promotional Giveaways
Key provisions of the UK's Tobacco and Vapes Act 2026 will take effect on Oct. 29, extending an age-18 sales restriction to all vaping and non-medicinal nicotine products. In England, Wales and Northern Ireland, the change brings zero-nicotine vapes within statutory age-of-sale rules and also covers products including nicotine pouches, strips and pearls. The law will also prohibit proxy purchasing for under-18s, consumer-facing vending machines, promotional giveaways and substantial discounts intended to promote vaping and nicotine products.
Regulations
Oct.10